• Home
  • Blog

Call us today! +1 (352) 353-0052

Find our Location
info@derivatixcapital.com
Login

Login
Derivatix Capital ManagementDerivatix Capital Management
  • Home
  • Blog

Derivatix Monthly Report: Month 32 as of Apr. 30th, 2018

Home ReportDerivatix Monthly Report: Month 32 as of Apr. 30th, 2018

Derivatix Monthly Report: Month 32 as of Apr. 30th, 2018

June 24, 2018 Report, Uncategorized
Picture

While the US Market stayed volatile in April, it didn’t get any specific direction and finished this month
with almost no overall change. S&P500 and NASDAQ added only 0.5% while Dow Jones showed no gain
in this month.

As previously mentioned, that is the desired situation for our sideway trading strategy where we bet on
the market’s gyration within one standard deviation of its historical volatility. Accordingly, while April
didn’t help the overall market to grow much, it did help us to make a good monthly profit.

Derivatix made 1.5% net profit in April which is 3 times higher than S&P500 and NASDAQ growth at this
month. This helped the fund to make 3.8% net profit for 2018 while NASDAQ was up 3.3% and the other
two (S&P500 and Dow Jones) are still negative territory year to date. Eventually, since fund’s inception
32 months ago, Derivatix is up almost 82%. That is about 25% average annual net growth after all fees.
It is expected that the US Market stays in a wide range in the rest of 2018 as performed in April which in
turn provides the fund with more sideway setups and chances to beat the benchmarks in this year.

​That would be a great opportunity to join the fund to enjoy the ride!

Share
0

You also might be interested in

2015 TARGET REACHED

Nov 22, 2015

​Derivatix First Options Fund reached its first major milestone by[...]

Derivatix Quarterly Report: Mid 2020-Q1 as of Feb. 29th, 2020

Derivatix Quarterly Report: Mid 2020-Q1 as of Feb. 29th, 2020

Mar 6, 2020

While the world is fighting against the coronavirus pandemic, don’t[...]

Derivatix Quarterly Report: 2020-Q3 as of Sep. 30th 2020

Derivatix Quarterly Report: 2020-Q3 as of Sep. 30th 2020

Oct 25, 2020

After a devastating 1st quarter for the global, market, followed[...]

Leave a Reply

Your email is safe with us.
Cancel Reply

You must be logged in to post a comment.

Recent Posts

  • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
  • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
  • Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
  • Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021
  • Derivatix Info Session Mar. 7th 2021
  • Derivatix Quarterly Report: 2020-Q4 as of Dec. 31st, 2020

Recent Comments

    Archives

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Comments

    Find us on

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Send Message

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.

    Contact Info

    • Derivatix Capital Management
    • 639 Bird Road, Coral Gables, Florida, 33146, USA
    • +1 (352) 353-0052
    • info@derivatixcapital.com
    • derivatixcapital.com

    Fresh from blog

    • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
    • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
    • Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
    • Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
    • Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
    • Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021

    © 2022 — Derivatix Capital Management.

    • Home
    • Blog
    Prev Next

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.